Home drug plan design

Keyword: drug plan design

82 results found

A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director of private payers and investment, during a session at Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The survey noted private payer review times can take […]

Pharmacists are now uniquely positioned to support Canadians at a time when the public health-care system is stretched thin, creating significant barriers for people looking to access care, said Dr. Jennifer Poh, senior director of drug plan solutions at Health Solutions by Shoppers, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in […]

With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate health support and employee satisfaction while also being cost effective, said Marie-Hélène Dugal, manager of pharmacy benefit strategy for Medavie Blue Cross, during Benefits Canada’s 2023 Face to Face Drug […]

Despite the safety and efficacy of biosimilars — and the potential cost savings they offer — uptake among private payers has been low historically and is only starting to gain steam, said Neda Nasseri, pharmacist and private payer product director at Desjardins Insurance, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The insurer first developed […]

It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing common hurdles within their own drug plans, said John Adams, chair of the board of directors for patient advocacy group Best Medicines Coalition, during a session at Benefits Canada’s 2023 Face […]

The 10 highest-cost drugs reimbursed by public drug plans in Canada in the 2021/22 fiscal year were all rare disease treatments with annual treatment costs of more than $250,000, according to a new report by the Patented Medicine Prices Review Board. It found the increased use of high-cost drugs continued to be the main factor […]

A story on how plan sponsors and insurers are considering covering weight-loss drugs as part of a broader push towards more inclusive benefits was the most-read benefits story on BenefitsCanada.com this year. Here are the 10 most popular benefits news stories of the year: 1. How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising […]

  • By: Staff
  • December 19, 2023 December 18, 2023
  • 09:00

TD Synnex Canada is modernizing its employee benefits plan by getting the best value for money while still protecting employees from a mental-health and well-being perspective, according to Shana Kapustin, the global information technology company’s senior director of human resources, speaking during an event hosted last week by the Group Insurance and Pharmaceutical Committee. “We’ve gone […]

  • By: Staff
  • November 6, 2023 November 9, 2023
  • 09:00
Copyright_ilixe48_123RF

An article on how global pension funds compare in terms of transparency was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. Five Canadian pension funds receive top scores for transparency: benchmark 2. How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use […]

  • By: Staff
  • July 21, 2023 July 21, 2023
  • 09:00

The annual Benefits & Pension Summit, which was hosted virtually on June 1, is the only Benefits Canada event that brings together health benefits and capital accumulation plans in one event. This year, delegates heard the results of Benefits Canada‘s exclusive CAP Member Survey with a panel of experts discussing the findings, case studies from two leading […]